UK Nurse's Death Sparks Debate on NHS Weight-Loss Jabs
TL;DR Summary
The death of Scottish nurse Susan McGowan has been linked to the weight-loss drug tirzepatide, branded as Mounjaro, which she took for two weeks before her death. Her death certificate cites multiple organ failure, septic shock, and pancreatitis, with the drug noted as a contributing factor. This is reportedly the first UK death associated with Mounjaro, a GLP-1 receptor agonist approved by the MHRA for weight loss. The drug's manufacturer, Lilly, emphasizes patient safety and ongoing monitoring of the drug's effects.
- Scots nurse’s death linked to weight-loss jab Mounjaro approved on NHS Daily Record
- Approved weight-loss drug contributed to UK nurse’s death, report says The Guardian
- Nurse dies after taking new NHS weight loss jab in first confirmed fatality linked to obesity drugs Manchester Evening News
- The obesity crisis: are weight-loss jabs the answer? Five University of Cambridge experts weigh in on the debate Cambridge Independent
- Nurse who tried Mounjaro becomes first confirmed UK death linked to NHS weight loss jabs The Mirror
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
3 min
vs 4 min read
Condensed
87%
632 → 81 words
Want the full story? Read the original article
Read on Daily Record